We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CABA market cap is 551.04M. The company's latest EPS is USD -1.5794 and P/E is -8.15.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -11.78M | -16.3M | -16.96M | -15.89M | -18.67M |
| Net Income | -11.43M | -15.69M | -15.85M | -14.49M | -16.45M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -18.68M | -33.83M | -46.31M | -54.14M | -74.66M |
| Net Income | -16.94M | -33.34M | -46.29M | -52.98M | -67.68M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 91.68M | 116.97M | 103.45M | 184.64M | 173.29M |
| Total Liabilities | 5.8M | 12.45M | 11.8M | 10.5M | 12.36M |
| Total Equity | 85.87M | 104.52M | 91.65M | 174.14M | 160.92M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 141.47M | 114.72M | 126.34M | 116.97M | 253.65M |
| Total Liabilities | 3.15M | 5.18M | 8.38M | 12.45M | 17.45M |
| Total Equity | 138.32M | 109.54M | 117.96M | 104.52M | 236.2M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -34.25M | -46.38M | -12.61M | -24.5M | -37.1M |
| Investing | -26.9M | -27.22M | 24.62M | -23.52M | -23.59M |
| Financing | 91k | 32.98M | 226k | 94.48M | 94.58M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -16.05M | -26.77M | -34.11M | -46.38M | -53.55M |
| Investing | -693k | -7.98M | 6M | -27.22M | -22.45M |
| Financing | 119.93M | -24k | 48.9M | 32.98M | 187.63M |
| Market Cap | 551.04M |
| Price to Earnings Ratio | -8.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 2.85 |
| Price to Book Ratio | 2.33 |
| Dividend Yield | - |
| Shares Outstanding | 42.85M |
| Average Volume (1 week) | 2.49M |
| Average Volume (1 Month) | 1.51M |
| 52 Week Change | 2.88% |
| 52 Week High | 26.35 |
| 52 Week Low | 9.02 |
| Spread (Intraday) | 1.37 (10.53%) |
| Company Name | Cabaletta Bio Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.cabalettabio.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
